What is the recommended dosing schedule and booster timing for the Dukoral (cholera) vaccine for the various age groups?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 9, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Dukoral Dosing Information Not Available in Provided Evidence

I cannot provide specific dosing recommendations for Dukoral (oral cholera vaccine) because none of the evidence provided contains official prescribing information, FDA labeling, or current guideline recommendations specifically addressing Dukoral's dosing schedule and booster timing across age groups.

What the Available Evidence Shows

The research studies provided discuss Dukoral only in the context of:

  • Limited efficacy in young children: Dukoral offered negative protection in children under 5 years of age in a Peruvian field trial, and only 15% protection in those over 6 years during the first year 1

  • Age restrictions in current recommendations: Dukoral is recommended for adults and only children over 2 years of age 2

  • Research on immunogenicity enhancement: A study in 6-18 month old Bangladeshi children showed two doses were safe and induced vibriocidal antibody responses in 57% of children, with enhanced responses when breast-feeding was temporarily withheld or zinc supplementation was provided 2

  • Immune response differences by age: Adults and older children mount class-switched IgG and IgA antibody responses to O-specific polysaccharide, while younger children (ages 2 to <5) primarily mount IgM responses with minimal IgA and IgG 3

Critical Gap

The provided evidence lacks:

  • Official manufacturer dosing schedules
  • Specific timing between doses
  • Booster dose recommendations and intervals
  • Age-specific dosing modifications
  • Current FDA or WHO prescribing guidelines for Dukoral

Clinical Context

The evidence suggests Dukoral has questionable effectiveness in the populations most vulnerable to cholera (children under 5 years), with concerns about vaccine composition using V. cholerae O1 strains from 1947 that have been heat and formalin inactivated 1. Alternative vaccines (Shanchol, Euvichol) are discussed in the research but are not the subject of your question 4.

To obtain accurate Dukoral dosing information, consult the official FDA prescribing information or current WHO/CDC cholera vaccination guidelines.

Related Questions

What is the recommended booster dose schedule for Dukoral (Cholera vaccine) in an adult or adolescent patient who received the initial administration over a year ago and remains at risk of cholera exposure?
What is the recommended schedule for a booster dose of Dukoral (cholera vaccine) in individuals who have previously received the vaccine and are still at risk of cholera infection?
What is the recommended vaccination protocol for a patient requiring protection against cholera, specifically using Dukoral (Vibrio cholerae O1) vaccine?
What is the proper administration and dosage of Dukoral (cholera vaccine)?
What are the dose guidelines for Dukoral (Cholera vaccine)
Can mometasone 0.1% cream be used to treat facial eczema?
What are the adverse effects of intravenous immunoglobulin (IVIG) when used experimentally to treat severe enterovirus-associated pneumonia in critically ill patients?
What is the appropriate treatment for acute pharyngitis in a 5‑year‑old child weighing about 32 lb with a known amoxicillin allergy?
What antibiotic regimen should be used for a patient with a purulent surgical‑site infection of the ankle who is allergic to penicillins and sulfonamides, in a skilled‑nursing‑facility setting?
How should I evaluate a patient with eosinophilia, fever, and splenomegaly to rule out parasitic infection, given recent travel to tropical or subtropical regions and possible exposure to raw or undercooked meat, freshwater, or animals?
What does Vraylar (cariprazine) do?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.